Cosmo’s diarrhea drug approved, threatening Salix’ cash cow

Ireland’s Cosmo Pharma claimed FDA approval for its traveller’s diarrhea drug Aemcolo, which some analysts say could be a big threat to a rival drug sold by Bausch Health’s Salix unit.